The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 28,701–28,800 of 31,469
Mohasseb, M., Nour, H. A., El-Sawaf, A., & Khalil, G. I. (2013) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2013.10.004
Nutritional recovery with rice bran did not modify energy balance and leptin and insulin levels
Martins, M. S. F., Oyama, L. M., Latorraca, M. Q., Gomes-da-Silva, M. H. G., & do Nascimento, C. M. O. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000300007
Ocena parametrów metabolizmu lipidowo-węglowodanowego u niemowląt
Kowalska, E., Toporowska‐Kowalska, E., Tomaszewska, M., Funkowicz, M., & Wąsowska‐Królikowska, K. (2007) · Pediatria Polska · doi:10.1016/s0031-3939(07)70379-7
Adipokines and cytokines in non‐alcoholic fatty liver disease: authors’ reply
Baranova, A. V., & Younossi, Z. M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03724.x
Colleran, K., Aguirre, L. E., & Burge, M. R. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.21024
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Mogawer, S., Mansour, M., Marie, M. A. S., et al. (2012) · Comparative Clinical Pathology · doi:10.1007/s00580-012-1560-0
Brandão, M., Lopes, C. M. M., & Ramos, E. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2011.142976l.6
Odaguchi, H., Wakasugi, A., Ito, H., et al. (2008) · 日本東洋醫學雜誌 · doi:10.3937/kampomed.59.53
N-terminal pro-B-type natriuretic peptide and insulin resistance in overweight and obese subjects
Alçelik, A., Aytekin, E., Tosun, M., Aktaş, G., Ayhan, S., Ozturk, S., Özlü, M. F., Şavlı, H., & Yazıcı, M. (2012) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.03.004
Trimeche, S., Dieudonne, J.-F. T. D., Jeandel, C., Paris, F., Brum, I. S., Orio, F., & Sultan, C. (2004) · EMC - Gynécologie-obstétrique · doi:10.1016/j.emcgo.2004.10.004
Why Serum Uric Acid Leads to Insulin Resistance in Japanese Females Working Abroad?
Iizuka, T., Toshihiro, K. O. G. A., Abe, S., et al. (2008) · Health Evaluation and Promotion · doi:10.7143/jhep.35.378
Mehanna, E. T., Saleh, S. M., Ghattas, M. H., et al. (2014) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2014.988631
Jeoung, M. J., Shin, J. Y., Kim, S., et al. (2007) · Korean Journal of Pediatrics · doi:10.3345/kjp.2007.50.8.767
Elevated C-Reactive Protein, Abdominal Obesity, and Glucose Tolerance Status in Japanese-Brazilians
Cardoso, M. A., Hu, F. B., Gimeno, S. G. A., Franco, L. J., Hirai, A. T., & Ferreira, S. R. G. (2007) · The Open Endocrinology Journal · doi:10.2174/1874216500701010001
Aterosclerosis intracraneal asintomática: prevalencia, factores clínicosy biomarcadores asociados
Elena López-Cancio, M. (2012) · TDX (Tesis Doctorals en Xarxa)
Ontogeny of Polycystic Ovary Syndrome: A Creative Approach
Witchel, S. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0591
Uncoupling protein-2 mRNA expression in mice subjected to intermittent hypoxia
Vieira, L. R., Martinez, D., Forgiarini, L. F., da Rosa, D. P., de Muñoz, G. A. O., Fagundes, M., Martins, E. F., Montanari, C. C., & Fiori, C. Z. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000004414
Çetinkalp, Ş., Erdoğan, M., Karadeniz, M., Berdelı, A., Tamsel, S., Özgen, G., Saygılı, F., & Yılmaz, C. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903215508
Association between Homa Index and Vascular Endothelial Dysfunction in Type 2 Diabetic Patients
Kumari, N., Raju, I. B., Devi, M. A., & Praveen, M. P. (2014) · Open Journal of Internal Medicine · doi:10.4236/ojim.2014.44019
Ramadhanzaidan (2011) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2011.40.44
Alkhouri, N., Mansoor, S., Giammaria, P., López, R., & Nobili, V. (2014) · Gastroenterology · doi:10.1016/s0016-5085(14)60040-8
Nguyen, U. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.384
Jeon, J.-Y., & Kwak, Y.-S. (2007) · Journal of Life Science · doi:10.5352/jls.2007.17.10.1419
A Unique Collaboration on a National Goal
Dougherty, M. C. (2005) · Nursing Research · doi:10.1097/00006199-200509000-00001
The insulin resistance syndrome—diagnosis and management
Hough, S. F. (2004) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2004.11073589
Calzado, M. C. G., & Nez-Corts, J. M. (2005) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(05)73754-1
Gianatti, E., Hoermann, R., & Grossmann, M. (2014) · Diabetes Care · doi:10.2337/dc14-1817
Kim, J. H., Kang, M. J., Shin, C. H., & Yang, S. W. (2009) · Korean Journal of Pediatrics · doi:10.3345/kjp.2009.52.3.370
Na, W., & Sohn, C. (2011) · 대한지역사회영양학회지 · doi:10.5720/kjcn.2011.16.6.762
Bigaillon, C., Chellak, S., Ceppa, F., Mayaudon, H., Dupuy, O., Garcia, C., Baigts, F., Bauduceau, B., & Burnat, P. (2005) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2005.05.004
Tull, E. S., Cort, M. A., & YARANDI, H. N. (2014) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-014-0133-5
A Study on the Factors influencing insulin resistance in obese adolescents
Jin, Y., & Dou, P.-F. (2008) · 南京医科大学学报：英文版 · doi:10.1016/s1007-4376(09)60014-9
Leak, T. S. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Effect of obesity on TAFI in postmenopausal period
Taşkıran, B., Güldiken, S., Demir, A. M., Okman, T. K., Arıkan, E., Turgut, B., & Tuğrul, A. A. (2010) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2010.05.001
Metabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka
Jayatissa, R., Yamori, Y., Silva, A. D., Mori, M., Gunawardana, S. D., Silva, U. D., & Ranbanda, J. (2014) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v4i1.7241
Chen, H., Lin, C., Chiu, Y., et al. (2014) · Blood Purification · doi:10.1159/000365136
Family history of diabetes: a risk analysis
Mataloto, P. A. M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Rašić-Milutinović, Z., Popović, T., Debeljak-Martačić, J., Peruničić-Peković, G., Borozan, S. Z., Ristić-Medić, D., Lačković, M., & Glibetić, M. (2014) · El Mednifico Journal · doi:10.18035/emj.v2i4.351
Is This Patient Insulin Resistant? How Much Does It Matter?
Sheeder, J. L., Travers, S. H., & Stevens–Simon, C. (2003) · Clinical Pediatrics · doi:10.1177/000992280304200911
Boyraz, M., Cınaz, P., Karaoğlu, A., et al. (2013) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2012-30524
Insulin resistance and the metabolic syndrome in obese children
Atabek, M. E. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.245
Vernet, M. V., Palacios, M. J. S., Fernández, E. J., et al. (2009) · Revista Clínica Española · doi:10.1016/s0014-2565(09)70351-0
Colson, A., Walker, D., BESSER, G. M., Grossman, A. B., Chew, S. L., Jenkins, P., Drake, W. M., & Monson, J. (2007) · Hormone Research in Paediatrics · doi:10.1159/000111811
Krentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_2
Rodilla, E., Costa, J. A., Pérez-Lahiguera, F. J., et al. (2008) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(08)71869-5
No Influence of Type 2 Diabetes on Chronic Inflammation and Oxidative Stress in Obese Patients
Cătoi, A. F., Pârvu, A. E., Mureșan, A., Bidian, C., Cătoi, C., & Pop, I. (2014) · Notulae Scientia Biologicae · doi:10.15835/nsb.6.1.9249
Efecto agudo de orlistat la lipemia posprandial
Cintora, H., González, C. D., Machain, M. G., Cintora, F. M., & Montero, J. (2003) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(03)78912-8
Morsy, M., Khashaba, A., Agamy, A. I., & Eid, R. (2014) · American Journal of Applied Sciences · doi:10.3844/ajassp.2014.1087.1098 · Cited by 1
Is Alanine Aminotransferase Associated with Osteopenia in Middle-Aged and Elderly Chinese?
Chen, G., Chen, L., Huang, B., et al. (2014) · Endocrine Practice · doi:10.4158/ep13166.or
Nishimura, K., Hirai, T., Nakazawa, S., Yamanaka, K., Kishikawa, H., & Ichikawa, Y. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.23051
Cardiovascular Autonomic Imbalance as a Predictor of Metabolic Syndrome in Adults Working Abroad
Iizuka, T., MIYAKE, T., Uchikoshi, A., et al. (2005) · Health Evaluation and Promotion · doi:10.7143/jhep.32.385
Pei, D., Lin, J., Wu, D.-A., Hsieh, C., Hung, Y.-J., Kuo, S., Kuo, K., Wu, C., & Li, J.-C. (2007) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2007.339
Vildagliptin Improves Glucose Tolerance and Decreases Plasma Triglycerides in Sprague-Dawley Rats
Koizumi, G., Kumai, T., Oda, G., Ohba, K., Tomoyori, E., Tokudome, T., Kawaguchi, K., Watanabe, M., Iwai, S., Matsumoto, N., et al. (2013) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.25.213
Serum Levels of 20-Kilodalton Human Growth Hormone (GH) in Children with Simple Obesity
Ishikawa, M., Satou, N., Kikuchi, T., et al. (2003) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.12.49
Protection bêta-cellulaire par les thiazolidinediones : quelles preuves aujourd’hui ?
Blicklé, J. F. (2007) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(07)88665-2
Aizawa, K., Shoemaker, J. K., Overend, T. J., & Petrella, R. J. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0099
Reduction of Plasma Adiponectin in Egyptian Obese Children with Nonalcoholic Fatty Liver Disease
Mohamed, A. A., Ghany, M. A., Shalaby, H., et al. (2015) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2015/13737
Horigome, M., Hattori, N., Kasai, H., Horigome, M., Sakurai, S., Oguchi, K., & Ikeda, U. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318217aeac
Role of interleukin-6 in states of metabolic health and disease
Holmes, A. G. (2010) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27354477
Economic benefits of pioglitazone for treating patients with Type 2 diabetes
Grossman, L. D., & Longo, C. J. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.2.135
METABOLIC SYNDROME IN PATIENTS WITH MITOCHONDRIAL DIABETES MELLITUS
Pranoto, A. (2007) · Folia Medica Indonesiana
Assessment of the metabolic syndrome in predicting incident type 2 diabetes in a Chinese population
Wang, J. (2005) · Työväentutkimus Vuosikirja
Efeitos da atorvastatina sobre a inflamação e resistência à insulina em camundongos obesos.
Furuya, D. T. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2008.tde-16032009-125905
Bertoni, A. G., Burke, G. L., Owusu, J. A., Vaidya, D. M., Barr, R. G., Jenny, N. S., & Rotter, J. I. (2010)
Perinatal essential fatty acid deficiency in mice - effects on metabolism and behaviour
Pálsdóttir, V. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Determinants of Cognitive Decline and Dementia in the Very Old
Euser, S. M. (2008) · RePub (Erasmus University Rotterdam)
Mortality and morbidity in patients with Addison's disease
Bergthorsdottir, R. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Association between Maternal Metabolic Syndrome and Metabolic Syndrome in Their Offspring
Hirschler, V., González, C. D., Molinari, C., et al. (2011) · Childhood Obesity · doi:10.1089/chi.2011.0049
de Luis, D. A., Aller, R., Conde, R., et al. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0151-1
Hiperinsulinemia y cambios en el espesor intima media de la pared arterial
Vergara, M. A. (2007) · Americanae (AECID Library)
Bastos, A. D. S. (2012) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences
Prakaschandra, R. (2013) · ResearchSpace (University of KwaZulu-Natal)
Moaty, M. I. A., Shebini, S. M. E., Mohamed, M. S., El-Arabi, N. H. A., Tapozada, S. T., & Hanna, L. M. (2012) · Macedonian Journal of Medical Sciences (University of Skopje)
Salles, R. F. N. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-10052010-165804
The role of leptin in endothelial dysfunction and cardiovascular disease
García, G. M., & Cruz, M. O. (2013)
Constructing clinical scoring systems to determine the need for an oral glucose tolerance test
DeLeo, J., Leonard, C., & Sumner, A. E. (2009) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn.2009.5178936
Usefulness of HOMA-IR index with an only insulinemia determination to diagnose an insulin resistance
Yero, J. A. H., Angela, I., Iglesias, T., Vargas, D., & González, G. (2011) · Revista cubana de endocrinología
The long term effects of rosiglitazone on serum lipid concentration and body weight
Shim, W. S., Do, M.-Y., Kim, S., et al. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.1.17
Regulation of Insulin Signalling by Exercise in Skeletal Muscle
Wadley, G. D. (2003) · Figshare
Karşıdağ, A. Y. K., Alkan, N., Büyükbayrak, E. E., et al. (2011) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.5505/tjod.2011.81488
Karolkiewicz, J., Pilaczyńska-Szczȩśniak, Ł., Deskur-Śmielecka, E., et al. (2009) · Wielkopolska Digital Library
EFFECTS OF EXERCISE TRAINING ON BRAIN BIOENERGETICS: LACTATE AS A KEY MEDIATOR
Lezi, E. (2013) · KU ScholarWorks (University of Kansas)
Regulation of food intake : a focus on ghrelin
Blom, W. A. M. (2005) · doi:10.18174/27836
Effects of dietary fibre on the human metabolism and metabolome
Johansson‐Persson, A. (2014)
Vascular risk factors and adipocyte dysfunction in metabolic syndrome
Hajer, G. R. (2008) · Utrecht University Repository (Utrecht University)
García, Y. G., Peña, G. M., Durán, R. S. P., & Suárez, R. G. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)
Tsuchiya, M., Yamasaki, T., & Sakaida, I. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01035.x
Risk factors of type 2 diabetes in Mexican and U.S. Pima Indians: Role of environment
Esparza‐Romero, J. (2010) · UA Campus Repository (The University of Arizona)
Gewichtsveränderungen unter Therapie mit Antiepileptika
Lechleitner, M. (2004) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Kim, M. K. (2014) · The Korean Journal of Obesity · doi:10.7570/kjo.2014.23.2.116
artigo original Influência da Idade e do Diabetes Sobre Esteróides Sexuais e SHBG em Homens
Bahia, L., & Gomes, M. B. (2003)
Homocysteinemia Is Not Changed by 3-Day Insulin-Induced Normoglycemia in Type 2 Diabetic Subjects
Beauvieux, M.-C., Rigalleau, V., Perlemoine, C., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2475
Leptin is Associated with Endothelial Dysfunction in Healthy Obese Premenopausal Women
Kwon, K., Choi, K., & Park, S.-H. (2007) · Korean Circulation Journal · doi:10.4070/kcj.2007.37.6.251
Impact of Candidate Genes on Obesity and Type 2 Diabetes
Långberg, E. (2011) · Figshare
In vivo estimation of gluconeogenesis
Chacko, S. K. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Regulation of the Expression of Adiponectin, Resistin and GLUT4 in Omental Adipose Tissue of Baboon
Tejero, M. E. (2003) · Texas ScholarWorks (Texas Digital Library)
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
